Send us Feedback

Advanced Medical Optics (EYE)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
OPERATING METRICS
REVENUE SOURCES
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

EYE » Topics » Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

This excerpt taken from the EYE 10-K filed Mar 2, 2005.

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

Dividends. We have never declared or paid any cash dividends on our common stock or any of our securities. We do not expect to pay cash dividends on our capital stock in the foreseeable future. We intend to retain our future earnings to continue to fund the development and growth of our business as well as repay long-term debt. In addition, our amended and restated senior credit facility prohibits us from paying cash dividends.

 

Market Information. The following table shows the quarterly price range of our common stock during the periods listed.

 

     2004
    2003

Calendar Quarter

    Low
    High
    Low
    High

First

    $ 20.04    $ 24.73    $ 11.30    $ 13.65

Second

      23.90      42.89      12.90      17.65

Third

      34.84      42.67      15.26      18.91

Fourth

      35.77      43.69      17.21      20.67

 

Our common stock is listed on the New York Stock Exchange and is traded under the symbol “AVO.” The closing price of our common stock was $37.95 on February 28, 2005.

 

The approximate number of stockholders of record was 4,515 as of February 28, 2005.

 

Recent Sales of Unregistered Securities. During the quarter ended December 31, 2004, the Company issued an aggregate of 260,382 shares of common stock to a limited number of holders of the Company’s 3 1/2% Convertible Senior Subordinated Notes due 2023 (the “3 1/2% convertible notes”) in exchange for approximately $4.8 million aggregate principal amount 3 1/2% convertible notes in privately negotiated transactions. The issuance of the shares of common stock was made in reliance on Section 3(a)(9) of the Securities Act of 1933, as amended.

 

Purchases of Equity Securities by the Issuer. The following sets forth the amount of 3 1/2% convertible notes acquired by AMO during the quarter ended December 31, 2004:

 

ISSUER PURCHASES OF EQUITY SECURITIES

 

Period

    Total Number of
Shares or Units
Purchased
   

Average Price

Paid per Share or

Unit

    Total Number of
Shares or Units
Purchased as Part
of Publicly
Announced Plans or
Programs
    Maximum Number
(or Approximate
Dollar Value) of
Shares or Units that
May Yet Be
Purchased Under the
Plans or Programs

September 25, 2004 – October 29, 2004

    None    —      None    None

October 30, 2004 – November 25, 2004

    $3,000,000 in
principal amount		    48.69 shares of
common stock for each
$1,000 principal
amount of notes and
accrued and unpaid
interest thereon		    None    None

November 26, 2004 – December 31, 2004

    $1,842,000 in
principal amount		    48.69 shares of
common stock for each
$1,000 principal
amount of notes and
accrued and unpaid
interest thereon		    None    None

 

25

Table of Contents

"Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities" elsewhere:

AngioDynamics (ANGO)
AtriCure (ATRC)
BECTON DICKINSON & CO (BDX)
BioLase Technology (BLTI)
Conceptus (CPTS)
Haemonetics (HAE)
Memry (MRY)
Retractable Technologies (RVP)
SonoSite (SONO)
Uroplasty (UPI)
Vascular Solutions (VASC)
West Pharmaceutical Services (WST)
Young Innovations (YDNT)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki